“The outlook revision reflects our view of the continued softening of Memorial’s profitability in fiscal year 2016 as well as the continued operating margin compression year-to-date for fiscal [year] 2017, both of which are underperforming budget expectations,” said S&P analyst Wendy Towber. “The negative outlook also reflects our view of Memorial’s departure from a multiyear trend of stable financial metrics, due in part to declining inpatient volumes and a shift in payer mix.”
The ratings agency also affirmed the “A-” long-term rating on MHHC’s $53 million of series 2013 revenue bonds.
More articles on healthcare finance:
S&P assigns ‘AA-‘ rating to Froedtert Health’s debt
Moody’s affirms ‘A1’ rating on Memorial Health System’s bonds
Moody’s affirms ‘Baa2’ rating on Pacific County Public Hospital District’s debt
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
